FDA Issues Proposed Rule to Implement Reporting Requirements for Right to Try Law
- July 24, 2020
The Food and Drug Administration (FDA) published July 24 (85 Fed. Reg. ) a proposed rule to implement a requirement for sponsors and manufacturers to provide an annual summary to the agency for investigational drugs they provide to patients under the Right to Try Act.
ARTICLE TAGS
You must be logged in to access this content.